SCHEMBL31436045

SCHEMBL31436045

CC(C)(C)OC(=O)NCCCNc1nc(NCCCNC(=O)OC(C)(C)C)nc(NCCN2CCOCC2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.49
CD274 Q9NZQ7 1/20 0.48
TSHR P16473 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MERTK Q12866 2/20 0.45
TYRO3 Q06418 1/20 0.45
GAS6 Q14393 1/20 0.45
ADORA2A P29274 1/20 0.44
ADORA2B P29275 1/20 0.44
ADORA1 P30542 1/20 0.44
RAB9A P51151 1/20 0.44
STK17B O94768 1/20 0.44
STK17A Q9UEE5 1/20 0.44
DRD2 P14416 6/20 0.43
BACE1 P56817 1/20 0.43
EGFR P00533 1/20 0.43
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31436126 0.90 STK17B (0.46) ADORA2AADORA2BADORA1STK17BSTK17A
SCHEMBL31436105 0.88 DRD2 (0.47) ADORA2AADORA2BADORA1STK17BSTK17A
SCHEMBL31436085 0.88 ACHE (0.46) ADORA2AADORA2BADORA1STK17BSTK17A
SCHEMBL31436068 0.85 STK17B (0.43) MERTKADORA2AADORA2BADORA1STK17B
SCHEMBL2850188 0.83 CD274 (0.51) CD274DRD2LMNA
SCHEMBL39968 0.83 LMNA (0.58) CD274RAB9ADRD2LMNA
SCHEMBL39934 0.83 CD274 (0.60) CD274TSHRDRD2LMNA
SCHEMBL31436060 0.83 STK17B (0.58) BRD4TSHRMEN1KMT2AADORA2A
SCHEMBL9093109 0.78 CD274 (0.53) CD274TSHRDRD2LMNA
SCHEMBL31436080 0.78 TDP1 (0.58) BRD4TSHRMEN1KMT2AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025088570-A1 IONIZABLE LIPIDS AND IONIZABLE LIPID NANOPARTICLES CRISPR THERAPEUTICS AG (CH) 2025-05-01 WO disclosed